BridgeBio Pharma, Inc. (BBIO)
74.29
+0.02
(+0.03%)
USD |
NASDAQ |
Nov 06, 16:00
74.40
+0.11
(+0.15%)
After-Hours: 20:00
BridgeBio Pharma EPS Diluted (TTM) : -3.040 for Sept. 30, 2026
EPS Diluted (TTM) Chart
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| September 30, 2026 | -3.040 |
| June 30, 2026 | -3.569 |
| March 31, 2026 | -3.746 |
| December 31, 2025 | -3.784 |
| September 30, 2025 | -4.187 |
| June 30, 2025 | -4.094 |
| March 31, 2025 | -3.531 |
| December 31, 2024 | -2.847 |
| September 30, 2024 | -2.412 |
| June 30, 2024 | -2.636 |
| March 31, 2024 | -3.228 |
| December 31, 2023 | -3.949 |
| September 30, 2023 | -3.907 |
| June 30, 2023 | -3.752 |
| March 31, 2023 | -2.835 |
| December 31, 2022 | -3.263 |
| September 30, 2022 | -3.355 |
| June 30, 2022 | -3.490 |
| Date | Value |
|---|---|
| March 31, 2022 | -4.079 |
| December 31, 2021 | -3.909 |
| September 30, 2021 | -3.904 |
| June 30, 2021 | -3.822 |
| March 31, 2021 | -4.200 |
| December 31, 2020 | -3.803 |
| September 30, 2020 | -3.419 |
| June 30, 2020 | -2.951 |
| March 31, 2020 | -2.626 |
| December 31, 2019 | -2.344 |
| September 30, 2019 | -2.165 |
| June 30, 2019 | -2.168 |
| March 31, 2019 | -1.718 |
| December 31, 2018 | -1.524 |
| September 30, 2018 | -1.079 |
| June 30, 2018 | -0.5635 |
| March 31, 2018 | -0.3031 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 19.80 |
| Ionis Pharmaceuticals, Inc. | -3.473 |
| Pfizer Inc. | 0.6992 |
| Cytokinetics, Inc. | -6.038 |
| Vertex Pharmaceuticals, Inc. | 15.55 |